Ben Goldsborough said he was opening up about his cancer diagnosis in part to let his constituents know why his work might be ...
Groundbreaking personalized kidney cancer vaccines show promise in early clinical trials, triggering strong immune responses ...
A new drug delivery system shows promise for treating a rare, aggressive form of cancer affecting pregnant women and new ...
As part of The Wistar Institute's Melanoma Research Center, the Villanueva lab pursues new ways to overcome the challenge of melanoma drug resistance. In this paper, the group took aim at melanomas ...
She blamed irritable bowel syndrome, constipation and even a tight bra. Looking back, she had some classic symptoms of colon ...
David Edges from Solihull, is alleged to have been told that a change to his toe was likely to be a fungal issue and it was his wife Kelly who thought it could be cancer ...
Reported recurrence rates of lentigo maligna treated with Mohs micrographic surgery have ranged from 0.5 to 30.0% in the ...
The lab of The Wistar Institute's Jessie Villanueva, Ph.D., has identified a new strategy for attacking treatment-resistant melanoma: inhibiting the gene S6K2. .
An experimental vaccine for kidney cancer is off to a promising start. In data from a Phase I trial released this week, the ...
Teddi Mellencamp reveals graphic picture of her surgery scar in honor of World Cancer Day - The Real Housewives of Beverly ...
The lab of The Wistar Institute's Jessie Villanueva, Ph.D., has identified a new strategy for attacking treatment-resistant ...
All patients involved in the phase 1 trial of a personalized cancer vaccine for high-risk stage III/IV kidney cancer showed a successful anticancer immune response.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results